
Dana-Farber Genomic Score Predicts Progression to Multiple Myeloma
Newswise — BOSTON – A new risk assessment score developed by researchers at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard reveals how multiple myeloma, a form of blood cancer, begins and progresses from precancerous to malignant …